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Introduction 34
African swine fever (ASF) is a highly pathogenic viral disease of swine. Virulent strains cause acute 35 haemorrhagic fever in domestic pigs with mortality rates up to 100% (1) . There is currently no 36 effective vaccine or treatment (2). ASF is caused by African swine fever virus (ASFV), the only 37 member of the Asfarviridae family. The virus sits within the nucleocytoplasmic large DNA virus 38 (NCLDV) superfamily which also includes the Poxviridae. NCLDVs have large, double-stranded DNA 39 genomes and replicate in the cytoplasm of infected cells (3). ASFV replicates predominantly in the 40 cytoplasm of cells of the monocyte/macrophage lineage. ASFV evades the anti-viral defences in 41 these cells by modulation of a number of host-cell pathways including type I IFN induction (4), mechanisms. Eukaryotic cells produce multiple classes of sncRNA, including microRNAs (miRNAs), 48 74
The effect of ASFV infection on host miRNAs has been investigated in vivo by comparing miRNA 75 expression in pigs infected with a virulent strain to those infected with an attenuated strain (20) . 76
These authors identified 12 miRNAs that were differentially expressed. In addition a further study 77 looked in vivo at the potential for ASFV to encode its own miRNAs and concluded that ASFV does not 78 express miRNAs in vivo (21) . In our study, we investigated the effect of ASFV infection on sncRNA in 79 primary porcine alveolar macrophages in vitro. We found that virulent ASFV infection of primary 80 porcine macrophages had only a small impact on host miRNAs with only 6 out of 178 identified 81 porcine miRNAs differentially expressed over a 16 h time period. Interestingly, we discovered an 82 ASFV-encoded sncRNA that, when overexpressed, led to a significant reduction in ASFV replication. 83
84
Results 85 ASFV infection does not induce polyadenylation or decay of cellular miRNAs. VACV, the prototypic 86 poxvirus and NCLDV member, has been shown to induce widespread disruption of cellular miRNAs 87 via a process of 3' polyadenylation and decay (18) (17) . In order to investigate if ASFV shares the 88 ability of VACV to induce miRNA polyadenylation and decay porcine alveolar macrophages (PAMs) 89 were infected with the pathogenic ASFV Benin 97/1 strain and Vero cells were infected with the 90 Vero cell adapted ASFV strain, Ba71v. In parallel, PAMs and Vero cells were infected with VACV WR, 91 with the samples collected and processed for northern blotting as described. The miRNA miR-27b-3p 92 was selected as a probe for this experiment since it is extensively polyadenylated and degraded in 93 VACV-infected cells (18) . As expected, in VACV-infected Veros at 0 hpi mature miR-27b-3p was seen 94 as a lower band (Fig 1a arrow) but by 6 hpi this mature form was almost undetectable and there was 95 a higher molecular weight "smear" present in the lane, consistent with polyadenylation of the 96 miRNA (Fig 1a asterisk) . The higher molecular weight band above the smear in all lanes represents 97 the precursor miRNA. By 16 hpi there was near complete decay of all forms of miR-27b-3p. In 98 comparison, mature miR-27b-3p was present at all time points in ASFV-infected Veros, with no 99 evidence of polyadenylation or decay. In VACV-infected PAMs there was visible polyadenylation of 100 miR-27b-3p but an absence of decay. This is likely explained by VACV being unable to undergo a 101 complete replication cycle in PAMs (data not shown). There was no modification or reduction 102 detected in the amount of miR-27b-3p in ASFV infected PAMs. Levels of miR-27b-3p expression was 103 quantified and normalised to 5s (Fig 1b) . This highlighted the near 100-fold reduction in miR-27b-3p 104 expression in VACV infected Veros whereas in ASFV-infected Veros and PAMs no reduction was 105 detected. 106 107 In order to look comprehensively at the effect of ASFV infection on sncRNA, we utilised small RNA 108 sequencing. RNA was extracted and sequenced from three biological repeats of either mock or 109 ASFV-infected PAMs at 0, 6 and 16 hpi. Sequences aligning to 247 different mature miRNAs were 110 obtained, these were then filtered to only include sequences with an average ≥ 5 reads as these gave 111 higher quality boxplots, reducing the total number of miRNAs identified to 178. These accounted for, 112 on average, 73% of total trimmed small RNA reads. Data from a previous study investigating the 113 effect of VACV infection on host miRNAs was used as a comparison (18). In ASFV-infected cells there 114 was no variation in the miRNA proportion of the total small RNA reads at both early and late time 115 points compared to uninfected cells (Fig 2a) . This was in contrast to VACV-infected cells, which had a 116 30% reduction in miRNA reads at an early time point (6 hpi) and over 50% reduction at late times (24 117 hpi) (Fig 2b) (18). To assess the extent of ASFV-induced 3' modification of miRNAs, all trimmed 118 sequences were analysed for non-templated nucleotide (nt) 3' additions after nt position 19. No 119 difference was detected between mock and ASFV infected samples at both 6 and 16 hpi, with the 120 proportion of reads containing miRNAs with 3' mismatches remaining at approximately 17% (Fig 2c) . 121 VACV infection led to a significant increase in the proportion of 3' modified miRNA reads, which 122 increased from 10% in mock to 25% in infected samples at 6 hpi (Fig 2d) (18) . At 24 hpi, the 123 difference was less substantial and increased from 10% in mock to 15% in infected samples, though 124 was still statistically significant. (Fig 2d) . In a final analysis of 3' miRNA modification during ASFV 125 infection, the extent of 3' polyadenylation was examined by calculation of the proportion of miRNA 126 reads which contained 3 or more non-templated 3' adenosine residues beyond nt position 19. No 127 difference was detected between mock and ASFV infected samples at either 6 or 16 hpi (Fig 2e) . The 128 results from northern blotting and small RNA sequencing revealed that ASFV does not share the 129 ability of poxviruses to induce cellular miRNA polyadenylation and decay. 130 131 ASFV infection induces rapid changes in abundance of a select number of miRNAs. To determine if 132 ASFV infection induces differential abundance of specific miRNAs we used the small RNA sequencing 133 data to analyse changes in expression of individual miRNAs during infection, relative to mock 134 infected cells. The filtered data (miRNA ≥5 reads, 178 miRNAs in total) was used for this analysis. 135
MiRNAs were analysed for differential expression at 0, 6 and 16 hpi, relative to mock, and displayed 136 on volcano plots (Fig 3a-c) for each time point. The majority of cellular miRNAs were not 137 differentially expressed in response to ASFV infection. At both 6 and 16 hpi only one miRNA was 138 significantly differentially expressed (Fig 3b, c) . Expression of miR-10b increased 3.89 Log2 fold at 6 139 hpi and miR-27b-5p expression decreased 4.29 Log2 fold at 16 hpi. Interestingly, the time point with 140 the most changes in miRNA expression was 0 h (Fig 3a) . The 0 h samples were collected after the 141 virus had been incubated on the cells for 1h at 37°C. Four miRNAs were significantly upregulated at 142 this early time point: miR-10b, miR-486-1, miR-144 and miR-199a. Overall, the sequencing data 143 indicated that ASFV infection does not have a widespread impact on host miRNA expression, but 144 does lead to rapid changes in the abundance of a small number of miRNAs. 145
146
In order to validate the miRNA expression changes identified from the sequencing analysis RT-qPCR 147 was used to measure the abundance of individual miRNAs. Three more biological repeats of ASFV 148 infections were repeated in PAMs (taken from 3 different pigs), RNA extracted at 0, 6 and 16 hpi and 149 miRNA expression examined by RT-qPCR. To confirm that the miRNA expression changes were not 150 the result of unspecific stimulation of macrophages due to cell debris in the virus preparation, we 151 also tested miRNA expression by RT-qPCR after the addition of a mock virus preparation. In infected 152
PAMs, RT-qPCR validated the upregulation of miR-10b at 0h to comparable levels detected in the 153 sequencing (Fig 4a) however the upregulation at 6 hpi was not detected. Validation of miR-144 154 expression followed a similar pattern to the sequencing, though the upregulation was not as 155 substantial (Fig 4b) with a log2 fold change of only 2.2 compared to 7.81 found by sequencing. qPCR validation of miR-27b-5p expression showed a trend for downregulation but, again, this was 157 not as substantial as detected by sequencing with only log2 fold change of -1, compared to -4 in the 158 sequencing data at 16 hpi (Fig 4c) . RT-qPCR was unable to validate miR-486-1 upregulation (Fig 4d) . 159
We were also unable to validate expression of miR-199a-1 due to its low expression in PAMs. With 160 an average of only 17 miR-199a-1 reads per sample, a standard curve could not be generated. The 161 mock virus preparation did not lead to the dysregulation of any of the tested miRNAs (Fig 4a-d) . 162
163
We also analysed miRNA abundance in response to ASFV infection in Vero cells using the Vero cell 164 adapted stain, Ba71v. The expression pattern of the tested miRNAs did not follow that of Benin 97/1 165 infected PAMs with no substantial change in expression of any of the studied miRNAs (Fig 4e-f) , with 166 the log2 fold change not changing beyond ±1. Therefore, indicating either that the changes detected 167 in PAMs with Benin 97/1 were cell-type specific or strain specific. Overall, we conclude that ASFV 168 infection has a focused impact on the abundance of cellular miRNAs. This impact is limited to 169 upregulation of a small number of miRNAs (miR-10b and miR-144) at very early time points during 170 infection, specifically of Benin 97/1 infected PAMs. 171 172 Identification of three ASFV encoded small non-coding RNAs. As ASFV does not mirror poxviruses 173 by disrupting the host miRNA system on a widespread scale, there remains the potential for ASFV to 174 utilise this system to encode its own miRNAs. To investigate this possibility, we aligned small RNA 175 reads that did not map to known Sus scrofa sequences to the ASFV Benin 97/1 genome and the 176 Ba71V genome, as this is the only isolate to have fully sequenced terminal inverted repeats. Plotting 177 these aligned reads along the ASFV Benin 97/1 genome (Fig 5a) revealed a single peak of small RNA 178 reads at approximately 82000 bp. This was also detected when aligned to Ba71v (Fig 5b) . In addition, 179 the Ba71v alignment revealed two peals of small RNA reads at 57bp and 170022 bp, indicating that 180 these are located in genome termini. We termed these 3 small RNA sequences as ASFV small RNA 1,  revealed that these small RNAs were only detected in infected samples ( Fig 5 d , e, f) confirming that 186 these sequences are virally derived. Due to the higher mean abundance of ASFVsRNA2 and its 187 appearance at 6 hpi, this RNA was taken forward for further analysis. 188 189 Characterisation of ASFV-encoded small RNA2. The sequence of ASFVsRNA2 aligns anti-sense (on 190 the non-coding strand) to C147L (Fig 6a) , the RNA polymerase subunit 6. This region of the gene is 191 100% conserved in all sequenced ASFV genomes (Fig 6b) . Interestingly, ASFVsRNA2 had a variable 192 number of 3' U residues. A large proportion of reads contained 0 3' uridines, 90% at 6 hpi, which 193 decreased to 70% by 16 hpi (Fig 6c) . The number of reads containing 1 -12 3' U residues increased 194 over time from 10% at 6 hpi to 30% by 16 hpi (Fig 6c) . The first 9 U residues are templated in the 195 viral genome (depicted in Fig 6b) though around 10% of all reads have 10-12 at 16 hpi. 196 197 Expression of the ASFVsRNA2 was validated using RT-qPCR. RNA from both ASFV Benin 97 /1 infected 198 PAMs and Ba71v infected VEROs was extracted at 0, 6 and 16 hpi. RT-qPCR was performed using a 199 primer specific for ASFVsRNA2 (without the polyU sequence). ASFVsRNA2 was detectable at very low 200 levels at 0 hpi (Fig 7a) , with 40-Ct values 5 or below in both cell types. By 6 hpi, ASFVsRNA2 was 201 readily detected with a mean 40-Ct value of at least 12 in both cell types, and even more abundant 202 by 16 hpi, with the 40-Ct value increasing by at least 2. Next, in order to visualise ASFVsRNA2, 203 northern blotting using a radiolabelled DNA probe perfectly complementary to ASFVsRNA2 was 204 performed on the same cellular RNA samples. The 5S ribosomal RNA was used as a loading control. 205
The probe detected a small RNA species in infected PAMs at 6 hpi, increasing in intensity by 16 hpi. A 206 similar band also appeared in infected VEROs at 16 hpi (Fig 7b) . 207
208
To assess ASFVsRNA2 expression in vivo, RNA was analysed from tissues taken from pigs 209 experimentally infected with ASFV. Outbred pigs were challenged with ASFV OURT88/1 and 210 euthanised 5 days post challenge due to exhibiting moderate clinical signs consistent with ASF. At 211 post-mortem examination the submandibular, mesenteric, gastrohepatic and renal lymph nodes as 212 well as the spleen were taken from three pigs. Samples of the same tissues were also taken from 213 one uninfected animal. RNA was extracted and RT-qPCR performed using the ASFVsRNA2 specific 214 primer. ASFVsRNA2 was not detected in any of the samples taken from the uninfected animal. 215
ASFVsRNA2 was detectable in all samples from animals infected with ASFV, with 40-Ct values ranging 216 from 8 -12 ( Figure 7c ), indicating that ASFVsRNA2 is produced during in vivo infection. 217 218 ASFVsRNA2 is not produced through canonical miRNA biogenesis pathway. To investigate whether 219
ASFVsRNA2 is a miRNA, we investigated whether it is produced through the canonical miRNA 220 biogenesis pathway by assessing its loading into Argonaute 2 (Ago2), a key protein involved in 221 miRNA biogenesis. Lysates were harvested from ASFV infected PAMs and incubated with either an 222 anti-Ago2 antibody or non-immune rabbit sera as a negative control. Antibody-protein-RNA 223 complexes were immunoprecipitated, and western blotting performed to identify enrichment of 224 Ago2 in the anti-Ago2 antibody complexes compared to the non-immune antibody complexes and 225 the non-precipitated cell lysate (Fig 8a) . RNA was then extracted and RT-qPCR performed for 226
ASFVsRNA2 and the miRNA miR-21, a highly expressed miRNA known to be loaded in RISC. Data was 227 normalised to the small U6 RNA, which is not loaded in RISC. An eight log2 fold enrichment of miR-228 21 was detected in the complexes precipitated with the anti-AGO2 antibody, confirming the success 229 of the IP (Fig 8b) . However, ASFVsRNA2 was very poorly enriched (log2 fold-change of 1) after IP, 230
indicating that ASFVsRNA2 is likely not produced through the canonical miRNA biogenesis pathway. 231
We additionally used the miRNAFold program (22) to predict if the ASFVsRNA2 can form a miRNA 232 stem-loop precursor. However, none of the in silico hairpin structures produced were convincing as 233 miRNA hairpin precursors (data not shown). 234
235
Overexpression of ASFVsRNA2 reduces viral replication. We next sought to investigate whether 236 ASFVsRNA2 performs a function during ASFV replication. We bypassed the canonical miRNA 237 biogenesis pathway by synthesising single-stranded RNA mimics of the ASFVsRNA2 with and without 238 the 3' polyU sequence. These RNA mimics were stabilised with 2'-fluoro modifications as other 239 sncRNAs have been shown to be functional and have targeting activity with this modification (23). 240
The experiments were performed in Vero cells using Ba71v rather than PAMs due to the higher 241 transfection efficiency of Vero cells. The ability of Vero cells to be both transfected with an RNA 242 mimic and infected with ASFV was first examined. Cells were transfected with a Dy547-labelled 243 miRNA mimic, miRDIAN and at 12 h later infected with ASFV Ba71v (After a further 24 h cells were 244 fixed, permeabilized, and labelled with an antibody targeted to ASFV early CP204L/p30 protein. 245
Analysis by confocal microscopy showed that all ASFV infected cells (p30 positive) were also 246 transfected with the miRNA mimic, visible as red dots on the images (Fig 9a) , indicating transfection 247 and infection of the same cells had occurred. 248 249 A single-step ASFV growth curve was then carried out on Vero cells transfected with either the 250 ASFVsRNA2 mimic, ASFVsRNA2 polyU mimic, a negative control mimic or left untransfected. After 12 251 h, cells were infected with ASFV Ba71v and the amount of virus present determined at the time 252 points shown by calculating the TCID50 (Fig 9b) . The negative control mimic had no effect on viral 253 replication, with no difference in viral TCID50 at any time point compared to the non-transfected 254 cells. At 12 hpi, ASFV replication in cells transfected with the ASFVsRNA2 mimic had an 255 approximately 0.5 log reduction in comparison to the non-transfected cells. Replication in these cells 256 recovered by 24 hpi to a similar level as the negative control and non-transfected cells. Interestingly, 257 the ASFVsRNA2 polyU mimic had a significant impact on replication only at 24 hpi, with an 258 approximately 1 log reduction. The results therefore suggest that ASFV utilises both the 3' uridylated 259 and non-uridylated forms of this virally-encoded small RNA to regulate its own replication, and that 260 the two forms are involved at different time points during replication. 261 262 Discussion 263
With no effective vaccine or treatment, methods to control ASFV outbreaks are limited. As a result, 264 after reaching the European Union (EU) in 2014 ASFV has subsequently spread throughout eastern 265
Europe. In addition, the virus emerged in China in 2018 and has since spread rapidly across South 266
East Asia with outbreaks declared in Vietnam, Cambodia, Mongolia and Hong Kong (24) . ASFV in 267
China has substantially impacted the food security in the world's largest pig producer (25). 268
Improving current ASFV vaccines and developing novel vaccines is therefore a priority. We therefore 269 sought to investigate the interaction between ASFV and sncRNAs in order to gain more knowledge of 270 ASFV host-pathogen interactions. Many viruses have been found to exploit and manipulate sncRNAs. 271 This can range from subtle effects on specific host miRNAs to widespread disruption of miRNAs, such 272 as in the case of poxviruses (17, 18) . The mechanism of VACV-mediated miRNA polyadenylation is 273 assumed to be mediated by the virally-encoded poly(A) polymerase (PAP), VP55 (17). The viral PAP is 274 conserved throughout the NCLDV superfamily with the C475L gene identified as the putative ASFV 275 PAP (26). We therefore first investigated whether ASFV shares the ability of poxviruses to induce 276 miRNA polyadenylation and their subsequent decay. Both northern blotting and small RNA 277 sequencing revealed no evidence of widespread miRNA polyadenylation and decay in ASFV-infected 278 cells. This characteristic is therefore not conserved throughout the NCLDV superfamily and may be 279 unique to poxviruses. 280
281
In contrast to poxviruses, this study found ASFV infection has only a modest impact on host miRNAs, 282 with only 6 miRNAs identified by sequencing to be differentially expressed during ASFV infection, 283 and only 3 of these robustly validated by RT-qPCR. This more subtle effect on miRNAs is more 284 common in virus infections than the widespread disruption that poxviruses induce (27). For example, 285 pseudorabies virus infected porcine dendritic cells led to the differential expression of only 8 miRNAs 286 (28). A previous study examined miRNA expression in spleen and lymph node collected from pigs 287 inoculated with a virulent and attenuated ASFV strain (19). This study identified differential 288 regulation of 22 miRNAs in the spleen and 33 in the lymph node 3 days post inoculation. The only 289 miRNA identified common to this study was miR-10b, which was found to be lightly downregulated 290 between 3 and 7 dpi animals infected with a virulent ASFV strain. It is difficult to directly compare 291 results as the previous study compared miRNA expression in pigs infected with a virulent strain to 292 those infected with an attenuated strain, not uninfected animals. Additionally, our in vitro study 293 focused on a single viral replication cycle over 16 hours whereas the in vivo experiment analysed 294 viral infection over multiple days. However, the identification miR-10b as differentially expressed in 295 vivo supports our theory that miR-10b plays a role during ASFV infection. 296
297
The upregulation of miR-10b occurred at 0 hpi, after the virus has been incubated on cells for only 1 298 h, but then rapidly decreased in abundance by 6 hpi. Further experiments using the porcine 299 pestivirus classical swine fever virus (CSFV) also led to a similar pattern in miR-10b expression, with 300 rapid upregulation of during the first hour of infection and subsequent decrease (data not shown). 301
Both ASFV and CSFV are enveloped viruses and have been found to enter porcine macrophages via 302 endocytosis (29) (30). In macrophages, miR-10b is known to target ATP binding cassette transporter 303 A1 ABCA1 (31), which is involved in the regulation of cholesterol efflux. During infection with ASFV, 304 cholesterol remodelling is essential in the establishment of productive viral infection and disruption 305 of cellular cholesterol efflux leads to the impairment of virus entry and viral particles remained 306 trapped in endosomes (32). This therefore suggests a link between miR-10b, ABCA1 and cholesterol 307 efflux during endocytic-mediated entry of ASFV in macrophages. 308
309
A key finding of this study was identification and characterisation of an ASFV-encoded sncRNA, 310
ASFVsRNA2. Due to their large genome size, DNA viruses have the coding capacity to encode miRNAs 311 and many do, predominantly the nuclear replicating herpesviruses. As canonical miRNA biogenesis 312 begins in the nucleus with host RNA Pol II transcription from the viral genome, it is assumed viral 313 miRNA biogenesis requires a nuclear phase of viral replication. Indeed, virus-encoded miRNAs have 314 been identified in NCLDVs that also have a nuclear phase of replication. These are in two 315
Iridoviruses: Singapore grouper iridovirus (SGIV) (33) and Tiger Frog Virus (TGV) (34). Several studies 316 have identified the presence of ASFV genomes in the nucleus at early time points in infection (35), 317 this nuclear phase remains poorly understood but it indicates the possibility for ASFV to encode 318 miRNAs. 319 320 Our study identified ASFVsRNA2 in both PAMs and tissues from pigs with ASFV (Fig 7a-c) . A previous 321 in vivo study concluded that ASFV does not express viral miRNAs in experimentally infected pigs (21). 322
However, the previous study restricted its analysis to miRNA only based on predictions of pre-cursor 323 miRNA structures and did not consider other classes of sncRNA. Since a number of virus families 324 encode different classes of sncRNAs (reviewed in (14)) we chose to sequence the small RNA fraction 325 from ASFV-infected cells without bias, and therefore allowed us to report the first identification of 326 an ASFV-encoded sncRNA. 327 328 Our research has indicated that ASFVsRNA2 does not fit the classic miRNA biogenesis pathway as it 329
does not have an identifiable hairpin precursor and fails to enrich in an Ago2 immunoprecipitate. 330
However, it is known that a number of viral miRNAs are produced though non-canonical pathways. 331 (36). For example, miRNAs encoded by murine γ-herpesvirus 68 (MHV68) in which the pre-cursor 332 miRNAs are located in a tRNA-like structure. (37). Despite this variety of biogenesis pathways, 333 miRNAs are required to be loaded into an Ago protein in order to function. Pigs, like other mammals, 334 have been found to encode 4 Ago proteins (Ago1-4) (38), though only Ago2 is catalytically active and 335 has the ability to cleave target mRNA (39). It has been reported that miRNAs are not sorted into 336 distinct human Ago proteins (40) and so miRNAs would be expected to be found in all Ago proteins. 337 Therefore, our inability to detect ASFVsRNA2 enrichment in an Ago2 immunoprecipitation indicates 338 that ASFVsRNA2 is not a miRNA. 339
340
The presence of polyuridine (polyU) residues on the 3' end of ASFVsRNA2 is intriguing. The first 9 of 341 these uridine residues are templated in the ASFV genome, though a small percentage of reads at 16 342 hpi have 10-12 uridine residues. It is likely that the variation in the number of templated uridine 343 residues is a result of ASFVsRNA2 biogenesis. ASFV transcription termination takes place at a 344 conserved motif of seven or more consecutive thymidylate residues (41) and this poly(T) motif is 345 retained in the mRNA (42). As the location ASFVsRNA2 maps to in the genome does not correspond 346 to a 3' end of any known gene, this polyU motif could be the termination signal for ASFVsRNA2 347 transcription. The non-templated additions may indicate a modification to ASFVsRNA2 as the main 348 function of non-coding RNA uridylation is to promote it degradation (43). However, it can also have a 349 number of other functions. For example, uridylation of the miRNA let-7 pre-cursor is required for let-350 7 biogenesis (44). It can also control the activity of non-coding RNA, for instance uridylation of miR-351 26 prevents it binding to its target IL-6 transcript but does not affect miRNA stability (45). The 352 functional significance of the uridine residues, templated or not, on the 3' end of ASFvsRNA2 is 353 currently unknown, though our work has indicated it is of importance. 354
355
Overexpression of ASFVsRNA2 reduced ASFV replication in Vero cells, suggesting it has a role in the 356 control of viral replication. This relatively modest effect, between 0.5-1 log reduction, is consistent 357 with sncRNA gene targeting since miRNAs usually regulate gene transcript levels by less than 2-fold 358 (46). Even though we do not believe ASFVsRNA2 to be a miRNA, the predominant function of all 359 classes of sncRNAs is to induce gene silencing (47). Therefore, we would also expect ASFVsRNA2 to 360 have only a modest effect. Many viruses are known to encode activators and repressors to finely 361 control their life cycle in order to replicate in the face of the host immune response. An interesting 362 example of this is the Human Cytomegalovirus (HCMV) encoded miRNA, miR-UL112-1, which has 363 been found to downregulate multiple viral genes involved in replication, leading to a decrease in 364 genomic viral DNA (48). 365
366
In summary, we have found that ASFV infection has a very modest impact on host sncRNA and 367 instead utilises this system to encode its own, ASFVsRNA2, which retards viral replication. The infected with ASFV or VACV at an MOI of 10 for 1h at 37°C. The inoculum was removed (0h time 404 point), cells were washed 3x in PBS and media, containing 2.5% serum, was replaced. At 0, 6 and 24 405 hpi cells were harvested into an appropriate volume of QIAzol lysis reagent (Qiagen) and RNA 406 prepared using the miRNeasy Mini Kit (Qiagen). For RNA extraction from animal tissues, the tissues 407 were harvested into RNAlater (Life Technologies) and stored at -80°C. 50mg of tissue was added to 408 700μl Qiazol lysis reagent (Qiagen) and homogenised using tissue grinding lysate matrix beads (MP 409 Biomedicals). RNA was prepared using the miRNeasy Mini Kit (Qiagen), including an on-column 410 DNase digest (Qiagen). 411 412 Northern blot analysis. Northern blotting was carried as described in (18). Briefly, 5µg RNA was 413 mixed with 2x TBE-UREA buffer (Novex) and heated at 70⁰C for 3 min. Samples were run on a 15% 414 polyacrylamide TBE-UREA gel (BioRad). The gel was then transferred to a solution of 0.5 x TBE 415 containing 10,000 x SYBR gold (Invitrogen) and visualised under UV light to check for equal loading. 416
The RNA was transferred to a Hybond N + membrane (Amersham) using a semi-dry transfer machine 417 and cross-linked as described in (51). DNA probes perfectly complementary to a small RNA were 418 prepared by labelling with P 32 using the mirVana probe and marker kit (Ambion) Membranes were 419 pre-hybridised in ULTRAhyb hybridisation buffer (Ambion) for 1hr at 42⁰C prior to incubation with a 420 P 32 -labelled DNA probe, overnight at 42⁰C. Membranes were then washed twice in 2x SSC with 0.1% 421 SDS for 15 min and laid against a phosphorimage screen for 4-6hrs. Labelling was detected using a 422
Typhoon FLA 7000 phosphorimager (GE Healthcare). To strip the membrane for re-probing it was 423 washed in a solution of boiling 0.1% SDS for 30min. 424 425 Small RNA sequencing. Integrity of the RNA was measured on a Bioanalyzer (Agilent), with all 426 samples having a RIN value of 8 or above. Small RNA sequencing libraries were prepared using 427
CleanTag small RNA kit (TriLink). Libraries were pooled, gel purified on a 5% polyacrylamide TBE gel 428 (BioRad) and sequenced on an Illumina HiSeq (Edinburgh Genomics). An average of 7013808 ± 429 3522153 reads per samples were generated. Quality of reads was assessed using FASTQC and 430 adapters trimmed using cutadapt software. Sequences were collapsed within each sample to 431 generate a non-redundant set of fasta sequences. Singletons were not included. The reference used 432 for alignment was version 10.2 of the Sus scrofa genome obtained from Ensembl, only full-length 433 perfect match (FLPM) sequences were counted. Sequences aligning to the genome were 434 subsequently used as input for a mirDeep2 analysis. Alignments were performed using a non-current 435 version of bowtie-based Perl script (mapper.pl) that forms part of the mirDeep2 software package. 436
The mirDeep2 version was 2.0.0.4 and the bowtie version was 0.12.5. Parameters used were -o 20 -l 437 17 -r 100 -c. The analysis used Sus scrofa mature (3p and 5p forms) and precursor sequences 438 obtained from mirBase (release 21). Small RNA reads that did not map to Sus scrofa sequences on 439 mirBase were aligned to the ASFV BA71V genome (Genbank: U18466.2) and ASFV Benin 97/1 440 genome (Genbank: AM712239.1). Sequencing data was deposited in NCBI GEO database under 441 accession GSE115512 442 443 Differential expression analysis. Initial raw counts were filtered to only include those with an 444 average of 5 reads or more. The counts within each sample were converted to abundances, which 445 were (1) multiplied by one million to generate a reads set, (2) one count added to all to preclude 446 zero counts instances, and (3) the resultant values converted to log2 and quantile normalised. 447
Pairwise comparisons of sample groups were performed on the normalised tag counts using linear 448 modeling (Bioconductor limma package). A series of 6 group-wise comparisons using empirical 449
Bayesian approaches was undertaken to identify differences (fold changes). Significance values are 450 controlled for false discovery, yielding a more rigorous adjusted P value. 451 452 Quantitative reverse transcription PCR (RT-qPCR). cDNA was generated using the miScript II RT Kit 453 (Qiagen). qPCR was performed using the miScript SYBR Green PCR Kit (Qiagen) using miScript Primer 454
Assays for miRNAs and the using the QuantiTect SYBR Green PCR kit (Qiagen) for mRNA in a 455 Stratagene Mx3005P qPCR machine (Agilent). All qPCRs were performed in duplicate. Hs_RNU6-2_11 456 miScript Primer was used as a reference gene for sncRNA data normalisation and 18s rRNA was used 457 for mRNA data normalisation. The PCR efficiency of each miScript Primer was determined by 458 standard curve and the log2 fold change calculate by the Pfaffl method. 459 460 Immunoprecipitation and Western blotting. Lysates were prepared by washing cells x2 in ice-cold 461 PBS before addition of an appropriate volume of RIPA lysis buffer (ThermoFisher) supplemented 462 with protease inhibitor (Complete™ Protease Inhibitor Cocktail Tablets, Roche) and for 463 immunoprecipitation, RNase inhibitor (ThermoFisher). Protein concentrations were determined 464 using BCA Protein assay Kit (Thermo Scientific Pierce). For immunoprecipitation, equal amounts of 465 protein were incubated with either a rabbit polyclonal anti-Ago2 antibody or pre-immune rabbit sera 466 overnight at 4°C. This was followed by a 1h incubation at room temperature with 25μl Pierce protein 467 A Magnetic Beads (Thermo Scientific). The beads were washed and resuspended then either 468 prepared for Western blotting or added to Qiazol lysis reagent for RNA extraction. For western 469 blotting, lysates or bead suspensions were prepared by mixing 20µg of protein with 2X Protein 470 Sample Loading Buffer (Li-Cor) and heated to 98⁰C for 5min. Samples were loaded onto a 15% 471 polyacrylamide resolving gel, layered with a 5% stacking gel, alongside a pre-stained protein ladder 472 (Biorad) and the proteins separated by electrophoresis. Proteins were transferred to a PVDF 473 membrane using a wet transfer technique. Membranes were first blocked for 1 hr at room 474 temperature in a 1:1 mixture of PBS and Odyssey blocking buffer (Li-Cor) 
